Neo Comprehensive - Myeloid Disorders
164-gene DNA/RNA clinical assay for molecular evaluation of myeloid neoplasms.
- Developer
- NeoGenomics
- Intended use
- Other
- Cancer scope
- Myeloid malignancies
- Specimen
- Bone marrow aspirate, FFPE tumor tissue, Peripheral whole blood
- Molecular modality
- DNA mutation, RNA
- Current version
- Current 164-gene DNA/RNA Neo Comprehensive - Myeloid Disorders assay; product page updated 2026-07-27
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.